(Q44730910)

5 December 2017

title

Topical corticosteroid phobia in patients with atopic eczema (English)

1 reference

5 December 2017

0 references

Charman CR

1

1 reference

5 December 2017

Morris AD

series ordinal

2

1 reference

5 December 2017

Williams HC

series ordinal

3

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

British Journal of Dermatology

5 December 2017

published in

1 reference

5 December 2017

volume

142

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

931-936

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03473.X

5 December 2017

1 reference

Adult height in patients with childhood onset atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03473.X

The effect of percutaneously absorbed steroids on hypothalamic-pituitary adrenal function after intensive use in in-patients*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03473.X

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03473.X

Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03473.X

10.1046/J.1365-2133.2000.03473.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference